chrisvoncsefalvay/vaers-outcomes huggingface dataset:
heart pain was severe, right around the breast area; heart pain was severe, right around the breast area; felt "something" going through arms; BP went up to 151/95/Her blood pressure was 155 on the top and 97 on the bottom; HR 108; felt weak; felt real bad; pain in chest; fingers were cold/fingers, hands and toes got really cold/cold feet; This is a spontaneous report from a contactable consumer (patient). This 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 14Jul2021 as single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. The patient felt weak and was getting pain in chest on 15Jul2021. Her BP went up to 151/95 and HR 108 on 15Jul2021, her fingers were cold, felt "something" going through arms, and had cold feet. On 15Jul2021 about 3 o'clock, she felt real bad and real weak and she started getting pains in her chest. Her fingers, hands and toes got really cold and her chest was hurting terrible. The patient took half of a BP medication in the morning and in the evening; took it and things calmed down about an hour later. She said the "heart pain" was severe, right around the breast area, and she could feel her heart beating. She described the "skipping" as "go go, stop stop, go". She said that sometimes it would be strong and other times, not. On 15Jul2021, her blood pressure was 155 on the top and 97 on the bottom and her heart rate was 108 and she could feel it beating in her chest. She was wondering if she should get another one on 04Aug2021 based on her side effects. Outcome of the events was unknown.   The lot number for the vaccine, BNT162b2 , was not provided and will be requested during follow up.
Admitted with decreased appetite and generalized weakness and cough. Utilized nasal canula during admission due to increased shortness of breath.
Pt claims that she had pain at the injection site 3 weeks after the vaccination.   Pain started to spread out from the injection site causing muscle tightness in the arm.  Her range of movement for that arm has been limited due to the tightness.
Diarrhea, nausea, headache, chills, fever,--within first 24 hours after receiving the second dose. Nausea and fatigue persisted, along with the loss of appetite (as of this date, still no appetite...only being able to handle orange juice and saltine crackers); emotions are still a wreck; concentration level is still small; multi tasking is not doable; seem to lose words along the way in conversation.
This case involves an unknown demographics gender patient who experienced sick (illness) after receiving vaccine INFLUENZA VACCINE.  The patient past medical history, medical treatment, vaccination and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  It is unknown if the patient experienced any additional symptoms/events.  It is unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment for the event.  At the time of reporting, the outcome of events was reported as unknown.  There will be no information available on the batch number for this case.
Site: Pain at Injection Site-Mild, Systemic: Body Aches Generalized-Mild, Systemic: Chills-Mild, Systemic: Fever-Mild, Systemic: Headache-Mild
Red circular area on right are.  Itchy, sore.  Appeared about 4 days after second dose of Zmoderna.
Patient seen in emergency room with complaints of itchy rash covering entire body. Treated with Tylenol and Benadryl.
Developed rash looking like hives that came and went.  Given Claritin and Benadryl with little relief.  Seen in office once with complete resolution of symptoms on approximately 5/10/16.  Also had been treated with amoxicillin during this time and had several environmental triggers.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2022 at 12:38 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 19-Feb-2022 at 12:38 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  The patient received vaccine past its 30 day expiry date on 19-Feb-2022 at 12:38:41, booster. Vaccine went into 2 to 8 degree Celsius thaw state on about 24-Dec-2021. The vaccine was administered up until its manufacturing expiry date of 04-Apr-2022.  No treatment medication were reported.
Extreme fatigue, heavier than normal menstrual cycle the first month, missed menstrual cycle the second month
Localized swelling, redness and pain at site of injection, about 60 cm diameter.
Patient was accidently  given a pediatric pfizer vaccine instead of Moderna booster. No treatment necessary,  patient was informed of erroneous vaccine administration. Patient agreed to come back after 28 days for Moderna Booster.
Patient reported on screening form that first dose vaccination was 5/1/21. It was later identified that patient's first dose was actually 5/6/21. Patient received vaccination greater than 4 days early as authorized by CDC. No adverse effects reported.
Systemic: Abdominal Pain-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Medium, Systemic: Headache-Severe, Systemic: Vomiting-Severe, Systemic: Weakness-Severe
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), ABDOMINAL DISCOMFORT (Arm was sore) and MALAISE (Arm was sore) in a 96-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore). On 17-Jan-2021, the patient experienced ABDOMINAL DISCOMFORT (Arm was sore). On 19-Jan-2021, the patient experienced MALAISE (Arm was sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm was sore) and MALAISE (Arm was sore) outcome was unknown and ABDOMINAL DISCOMFORT (Arm was sore) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Hives; Dermatographia; Increase in allergies/Increased allergy reactivity; High histamine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 18 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 03Jul2021 12:00 (Batch/Lot number: unknown) at the age of 18 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "If covid prior vaccination: Yes" (unspecified if ongoing), notes: If covid prior vaccination: Yes. There were no concomitant medications. The following information was reported: URTICARIA (non-serious) with onset 05Jul2021 12:00, outcome "not recovered", described as "Hives"; MECHANICAL URTICARIA (non-serious) with onset 05Jul2021 12:00, outcome "not recovered", described as "Dermatographia"; HYPERSENSITIVITY (non-serious) with onset 05Jul2021 12:00, outcome "not recovered", described as "Increase in allergies/Increased allergy reactivity"; HISTAMINE LEVEL INCREASED (non-serious) with onset 05Jul2021 12:00, outcome "not recovered", described as "High histamine". The events "hives", "dermatographia", "increase in allergies/increased allergy reactivity" and "high histamine" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of urticaria, mechanical urticaria, hypersensitivity, histamine level increased.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Information has been received from a 39 year old female consumer with penicillin allergy and no pertinent medical history, who on 03-May-2010 was vaccinated with a dose of MMR II (lot# 666293/1740Y). Concomitant therapy included INDERAL, NORVASC and DIOVAN. It was reported that the patient had an anaphylactic reaction after receiving MMR II vaccine. The patient could not breathe and swallow. She had puffy eyes, tasted metals and was very weak. The patient went to the emergency room in an ambulance but was released 5 hours later. Then, the patient started to have heavy menstruation. It had been longer and heavier than normal. Her gums were also bleeding. At the time of the report, the patient had not recovered. Upon internal review anaphylactic reaction was considered to be an other important medical event. Additional information has been requested.
BODY ACHES; CHILLS; FEVER; TIRED(DAY AFTER VACCINATION); This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, chills, fever, and tired (day after vaccination). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills, body aches and tired(day after vaccination) was not reported. This report was non-serious.
Severe swelling in his left arm, beginning in upper arm, descending to his whole arm. Seen in ER, diagnosed with cellulitis, placed on clindamycin for 10 days.
P/W LUE warmth, 24 1/2 x 20 cm area or blanching erythema, Pt given benadryl prn.
Feel sick; Body Ache; Feeling lymph node was swollen; Feeling ache at the site of injection; A spontaneous report was received from a consumer concerning a 35-years-old, female patient who was participating in the mRNA-1273 Emergency Use Program and experienced multiple events of injection site ache, wide spread body ache, lymph node swollen and feel sick.  The patient's medical history was not provided. No concomitant medications were reported.  On 23 Dec 2020, prior to the onset of symptoms, the patient received their first of two planned doses of mRNA-1273 intramuscularly in her left arm for prophylaxis of COVID-19 infection. A few minutes later, she experienced the event injection site ache.  On 24 Dec 2020, the patient experienced wide spread body ache, lymph node swollen and feel sick. The treatment for the events included naproxen, and the symptoms were better.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome for the events, injection site ache, wide spread body ache, lymph node swollen and feel sick were considered as recovering/resolving.; Reporter's Comments: This case concerns a 35-years-old, female subject, who experienced a non-serious unexpected event of malaise and non-serious expected event of pain, injection site pain and lymphadenopathy. The event of injection site pain occurred one day after first dose of mRNA-1273 and the event of malaise, pain and lymphadenopathy occurred 2 days after first dose of mRNA-1273. The treatment medication included naproxen. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
12 and a half m teen seen for routine physical. Patient riding in car after receiving HPV (Merck) developed low back muscle spasm. See copy of of visit and append information.
Headache, Myalgia, Diarrhea,  FATIGUE, WEAKENSS, SORE ARM Narrative:  Other Relevant History:
RECIPIENT REPORTED LOW GRADE FEVER, FATIGE, RUNNY NOSE THAT BEGAN SEVRAL HOURS POST VACCINE(SAME DAY). SX LASTED 1-2 DAYS. REPORTED TO THIS NURSE ON 01/10/22.
Client presented to receive Pfizer booster. After receiving Pfizer booster client was outside observation area, RN noticed client was trying to cough and could not respond while holding her throat with both hands. Client was moved to zero gravity chair with guidance. Epi pen was prepared but not given, due to client coughing and not responding.  Vitals BP 132/86 HR 75 02 98%, the problem resolved on its own 3-5mins later.  client reported the tightness in her throat was gone, but throat was still ?itchy?. RN  offered Oral Benadryl to client. Client refused due to her recent gastric bypass surgery. Client was provided water and was able to swallow without difficulty. Upon evaluation RN , observed no swelling on tongue and no signs of hives. No swelling observed around site of injection in right arm. client?s throat feels slightly irritated but denied tingling or shortness of breath.  client?s throat continues to feel irritated from coughing, as well as outer left side throat itchiness. RN  offered oral Benadryl to client for the itching. Client refused oral Benadryl due to recent gastric bypass procedure she had undergone.  Client was ready to go home, RN  educated client on emergency room precautions for returning or worsening symptoms and recommended follow up with Primary care provider within 24 hrs. Client left vaccination site .
Pt. received flu shot 12/1/08, had soreness at site of injection. Still having pain @ injection site.
This spontaneous report was received from a physician referring to a 69 year old male patient, with Diabetes Mellitus and Dyslipidemia as concurrent conditions. On 02-JUL-2012, the patient was vaccinated with a dose of ZOSTAVAX (lot # reported as 1653AA, expiration date: 21-JAN-2013) (dose, frequency and route of administration were not reported). Concomitant therapies were not reported. On an unknown date in approximately 2012 (reported as "within weeks after receiving ZOSTAVAX"), the patient experienced chronic itch all over the body (pruritus generalized). It was stated that on an unknown date, the patient went to see the physician and was given gabapentin, hydroxyzine (manufacturer unknown), ZYRTEC and BENADRYL (doses, frequencies and routes of administration were unknown for this medications), to treat the pruritus generalized. The patient was not hospitalized. It was stated that the patient did not die nor had a significant disability or incapacity nor life threatening. At the time of the report, the outcome of pruritus generalized was reported as not recovered, and the relatedness of ZOSTAVAX with pruritus generalized was not reported. Additional information has been requested.
I didn't see maker, lot # of the Shingrix shot that I received.  This was the 2nd dose in 2 months.  About 12 hr after the shot, I had chills, headache, body aches and weak muscles.   Later while laying down, I had stomach pain - center of stomach area and fever.    The next morning, I was fine as well as my arm.  But later in the afternoon, I was extremely tired and took a 3-hr nap.   That evening I had same stomach pain - short while, while laying down.
pt recv vax & approx 4 1/2hr later mom returned w/pt;lt thigh @ inj site was red & swollen & seemed painful to touch;referred to ER & report was localized rxn;
Patient has had residual pain since receiving the vaccine; This case was reported by a pharmacist via call center representative and described the occurrence of residual pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd December 2021, the patient received the 1st dose of Shingrix. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced residual pain. On an unknown date, the outcome of the residual pain was unknown.   It was unknown if the reporter considered the residual pain to be related to Shingrix.     Additional Information: GSK Receipt Date: 16-MAY-2022 Reporter's Comment: Pharmacist reported that a patient had residual pain since receiving the Shingrix vaccine. The pharmacist wanted to know how to proceed after an event like this had occurred. The reporter consented to follow-up.
Lip and facial swelling on the left side of my face. Took 50 of benadryl which took several hours to work. Was placed on 3 days of prednisone to decrease the swelling. Prednisone did decrease the swelling. Spoke with my primary doctor on the phone as it was after hours by the time I called him who prescribed the prednisone.
Patient reported arm pain, lymph node swelling and flu like symptoms lasting approximately 48 hours following vaccination.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 42-year-old male patient received BNT162b2 (BNT162B2), on 08Jun2021 as dose 2, single (Batch/Lot number: unknown) at the age of 41 years for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history included: "Diabetes Mellitus Type 2" (unspecified if ongoing); "Diabetic retinopathy" (unspecified if ongoing); "GERD" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Erythromycin for allergies: Erythromycin; Fluorescein for Known allergies: fluorescein. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Paxlovid was received as COVID 19 treatment from 04Sep2022 to an unknown date in Sep2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events with the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
Flu; Initial information was received on 28-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a non-health-care professional.  This case involves an unknown age and unknown gender patient who experienced flu after receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (strength, dose, formulation, frequency, lot number and expiry date: not reported) via unknown route in unknown administration site for Flu (Influenza).  On an unknown date the patient had a non-serious event of flu (influenza) (unknown latency) following the administration of influenza vaccine.  It was reported, "I got the shot and still got the Flu."  No lab data was reported.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment.  Outcome: Unknown.
The day after receiving the vaccine the patient experienced swelling from the site of the injection upward into her neck and face. Patient took Benadryl which relieved some of the swelling but slight neck edema and anterior cervical lymphadenopathy remains.
Client sitting in chair for immunization, saw blood with injection. Immediately turned white and complained of a severe headache. Lost consciousness in the chair had tremors of extremities. client lowered to the floor. She regained consciousness within 2 minutes. Able to drink water and eat crackers. Parent with child soon after and stated child has passed out before. Mother gave child Mountain Dew and took her out of the clinic after 15 minute wait.
12/26/22 presents to ED for "hypertension". PMHx of "dementia, vertebral compression (2020), acute left iliac vein DVT with IVC filter placement (2020), diverticular bleeding with hemorrhagic shock"
Fatigue, Muscle Ache, Pain at injection Point with mild fever (99.1 to 99.7) Saturday 5/10/2021 fatigue, mild fever continued, pain at injection site, 5/10/2021 11PM fever hit 101.3 all symptoms gone Sunday 5/11/2021 morning with some mild injection site pain
I tested positive for COVID19 disease; I tested positive for COVID19 disease; This is a spontaneous report from a contactable consumer (patient) via Covid-19 Adverse Event Self-Reporting Solution. A 55-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular, administered in Arm Left on 17Mar2021 11:30 (lot number: EL3247; expiry date: unknown) at the age of 55-years-old, as dose 2, single; and intramuscular, administered in Arm Left on 24Feb2021 11:30 (lot number: EL3247; expiry date: unknown) at the age of 55-years-old as dose 1, single for COVID-19 immunization. Medical history included asthma and high blood pressure. Concomitant medications included amlodipine, quinapril, and budesonide, formoterol fumarate (SYMBICORT) taken for unspecified indications, start and stop dates were not reported. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in other facility. On 25Jul2021, the patient tested positive for COVID-19 disease. The event was considered serious, medically significant. The patient underwent lab tests and procedures which included nasal swab: positive on 25Jul2021. The patient has not been tested for COVID-19 since vaccination. Therapeutic measures were taken as a result of event which included ibuprofen, VItamin C, Vitamin D, Vitamin B12, Allegra and Advil sinus. The patient recovered from the event on unspecified date in 2021.
Throbbing and excruciating pain when she moves her arm up or forward. Went to ER on 9/20/17 at about nine PM and was given TYLENOL with codeine #3. Was given NORCO at the hospital but no relief. Getting a little relief from OTC local anaesthetic and TYLENOL.
Pt requested a Flu shot and a Covid vaccine at our Flu clinic. He did not present the right vaccination card and got vaccinated 6 days early. Vaccinated 09/11/2022 Last Vaccination Moderna 07/18/2022